Neuropsychology of Depression
Edited by Shawn M. McClintock and Jimmy Choi
Hardcovere-bookprint + e-book
Hardcover
orderMay 4, 2022
ISBN 9781462549276
Price: $79.00464 Pages
Size: 7" x 10"
Request a free digital professor copy on VitalSource ?Timely and authoritative, this unique volume focuses on neurocognitive aspects of depression and their implications for assessment, evaluation, clinical management, and research. Experts in the field explore the impact of depression on executive function, learning and memory, working memory, and other critical capacities, and present cutting-edge assessment tools and procedures. The neurocognitive effects of widely used antidepressant treatments are reviewed, from psychotropic medications and evidence-based psychotherapies to established and emerging neuromodulation technologies. Practical aspects of working with adults across the lifespan with depression are addressed, including ways to strengthen treatment engagement and adherence, and to incorporate cultural considerations.
“Recommended. Upper-division undergraduates. Graduate students, faculty, and professionals.”
—Choice Reviews
“Each chapter is written by one or more outstanding experts in the field and is a self-contained, fully referenced review of its particular topic. The editors have done an excellent job of making formats and writing styles compatible; each chapter has a helpful concluding summary, many with very specific clinical recommendations. This volume will be of great interest and utility to clinicians and researchers alike. It is a user-friendly yet comprehensive reference source that psychiatrists, psychologists, and any mental health professional who deals with depression will want to have on their office bookshelf. Drs. McClintock and Choi have done an outstanding job of tackling the subject of the neuropsychology of depression; their text will surely become a classic in the field.”
—The Journal of ECT
“The clinical acumen of the authors is evident….A comprehensive, evidence-based essential.”
—British Journal of Psychiatry
“A masterpiece—I anticipate that this book will quickly be adopted as an authoritative, comprehensive, and essential resource for behavioral health clinicians and scientists. The book is well written, highly informed, and accessible. Chapters take the reader on a journey that encompasses the clinical conceptualization and expression of depression and associated neurocognitive disorders, the neurobiology of these disorders, and the broad array of therapeutic options and approaches. I quite literally could not put this book down, and will recommend it to my colleagues and students as a 'go-to' resource when diagnosing and treating patients with mood disorders.”
—Kathleen A. Welsh-Bohmer, PhD, ABPP, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine
“This book leaves no stone unturned. With exquisite depth and extraordinary breadth, it seamlessly integrates knowledge from neuropsychology, psychiatry, and cognitive neuroscience. The impressive slate of contributors cover all aspects of depression—from cultural influences to neurobiological underpinnings; from theoretical perspectives to behavioral, medical, and neurocognitive presentations; and from assessment methods to traditional and experimental treatments. Chapters are well organized and read effortlessly, while providing a wealth of relevant and useful information. All health care providers who work with adults with depression will appreciate this book, not only as a reference guide, but also as an inspiration for approaching this perennial disorder comprehensively, innovatively, and with compassion.”
—Yana Suchy, PhD, ABPP-CN, Department of Psychology, University of Utah
“This is a tour-de-force examination of the neurocognitive dysfunctions of depression, written by a 'dream team' of distinguished scientists. The book is unique in providing a sophisticated, in-depth view of the most recent neurobiological and clinical findings on depression with a clarity that makes them accessible to investigators and clinicians. Beyond dissecting the neurocognitive origins of depression, the book offers a comprehensive account of psychosocial and biological treatments that makes it an exceptional guide for students and for physicians, psychologists, and other professionals encountering depression.”
—George S. Alexopoulos, MD, S. P. Tobin and A. M. Cooper Professor of Psychiatry and Director, Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine
Table of Contents
I. Scientific Foundations of Depression1. Depression and Major Depressive Disorder: Evolution of Diagnosis and Symptomatology, Haitham Salem, Jair C. Soares, & Sudhakar Selvaraj
2. Neuroanatomy and Neural Networks in Depression, Michelle Thai, Kathryn Cullen, & Bonnie Klimes-Dougan
3. Depression across the Adult Lifespan, Vonetta M. Dotson, Shellie-Anne Levy, Hannah R. Bogoian, & Andrew M. Gradone
4. Depression and Comorbid Neuropsychiatric Disorders, Sara Kashani & Olusola Ajilore
5. Depression and Comorbid Medical Illness, Laura Howe-Martin, Tori Knox-Rice, Deanna Denman, & E. Sherwood Brown
II. Neuropsychological Domains
6. The Role of Cognitive Reserve in Depression, Sonya Dhillon & Konstantine K. Zakzanis
7. Learning and Memory Systems, Adam A. Christensen & Margaret O’Connor
8. Working Memory in Depression, Ashleigh V. Rutherford & Jutta Joormann
9. Executive Functions in Depression, Muzaffer Kaser & Barbara J. Sahakian
III. Clinical and Neuropsychological Assessment
10. Major Depressive Disorder Diagnostic and Depressive Symptom Metrics, Benjamin D. Pace & Mustafa M. Husain
11. Clinical Neuropsychological Assessment of the Patient with Depression, C. Munro Cullum, David A. Denney, & K. Chase Bailey
12. Assessment of Actual Versus Feigned Depression with Symptom and Performance Validity Tests, Kyle Brauer Boone
13. Inclusion and Diversity, Kayla Tureson, Alaina I. Gold, & April D. Thames
IV. Neuropsychological Effects of Antidepressant Treatment
15. Psychotropic Medications, Joshua Rosenblat
16. Nutraceuticals, Julia Browne, David Mischoulon, & Jerome Sarris
17. Evidence-Based Psychotherapeutic Treatments: Adaptations for Neurocognitive Impairments, Melissa Milanovic, Heather McNeely, Aamna Qureshi, Margaret C. McKinnon, & Katherine Holshausen
18. Cognitive Remediation, Christopher R. Bowie, Michael W. Best, Tanya Tran, & Jenna E. Boyd
19. Exercise, Tracy L. Greer & Hunter Small
20. Electroconvulsive Therapy, Martha Finnegan & Declan M. McLoughlin
21. Magnetic Seizure Therapy, Jeena Thomas, Zhi-De Deng, Shriya Awasthi, & Sarah H. Lisanby
22. Implantable Neurostimulation Devices for Depression: Vagus Nerve Stimulation and Deep Brain Stimulation, Scott T. Aaronson & Alik S. Widge
23. Transcranial Magnetic Stimulation, Brian Kavanaugh & Paul Croarkin
24. Transcranial Direct Current Stimulation, Donel M. Martin, Adriano Moffa, & Stevan Nikolin
About the Editors
Shawn M. McClintock, PhD, MSCS, is Associate Professor and holds the Lydia Bryant Test Distinguished Professorship in Psychiatric Research in the Department of Psychiatry at The University of Texas (UT) Southwestern Medical Center. He is also Director of Research Training for the UT Southwestern Clinical Psychology Doctoral Program. Dr. McClintock is a globally recognized expert in the neurocognitive effects of depression and antidepressant neuromodulation therapeutics. Working on interdisciplinary health care teams, he has published numerous articles and book chapters on these topics. A recipient of the Robert A. and Phyllis Levitt Early Career Award from the Society for Clinical Neuropsychology, Dr. McClintock serves on the editorial boards of Neuropsychology Review and the Journal of ECT.Jimmy Choi, PsyD, is a senior scientist at the Olin Neuropsychiatry Research Center in the Hartford Healthcare Behavioral Health Network and research neuropsychologist at The Institute of Living in Hartford, Connecticut. He directs the hospital network's cognitive rehabilitation service, which provides clinical assessment and treatment to children, adolescents, and adults. Dr. Choi has conducted research on cognitive recovery in neuropsychiatric disorders at VA Connecticut, Yale University, and Columbia University.
Contributors
Scott T. Aaronson, MD, Institute of Advanced Diagnostics and Therapeutics, Sheppard Pratt Health System, Baltimore, MDOlusola Ajilore, MD, University of Illinois at Chicago, Chicago, IL
Shriya Awasthi, BS, National Institutes of Health, Bethesda, MD
K. Chase Bailey, PhD, ABPP-CN, Department of Psychiatry, Parkland Memorial Hospital, Dallas, TX
Michael W. Best, PhD, University of Toronto Scarborough, Toronto, Ontario, Canada
Hannah R. Bogoian, MA, Georgia State University, Atlanta, GA
Kyle Brauer Boone, PhD, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA
Christopher R. Bowie, PhD, Queen’s University, Kingston, Ontario, Canada
Jenna E. Boyd, PhD, McMaster University, Hamilton, Ontario, Canada
E. Sherwood Brown, MD, PhD, University of Texas Southwestern Medical Center, Dallas, TX
Julia Browne, PhD, Massachusetts General Hospital, Boston, MA; Durham VA Health Care System, Durham, NC
Adam A. Christensen, PhD, Baylor College of Medicine, Houston, TX
Paul Croarkin, DO, Mayo Clinic, Rochester, MN
Kathryn Cullen, MD, ABPP-CN, University of Minnesota Medical School, Minneapolis, MN
C. Munro Cullum, PhD, University of Texas Southwestern Medical Center, Dallas, TX
Zhi-De Deng, PhD, National Institute of Mental Health, Bethesda, MD
Deanna Denman, PhD, Orthopedics & Sports Medicine, Novant Health, Charlotte, NC
David A. Denney, PhD, University of Texas Southwestern Medical Center, Dallas, TX
Sonya Dhillon, PhD, CPsych, University of Toronto, Toronto, Ontario, Canada
Vonetta M. Dotson, PhD, Georgia State University, Atlanta, GA
Martha Finnegan, PhD, St James’s Hospital, Dublin, Ireland
Alaina I. Gold, BA, University of Southern California, Los Angeles, CA
Andrew M. Gradone, MA, Georgia State University, Atlanta, GA
Tracy L. Greer, PhD, MSCS, University of Texas at Arlington, Arlington, TX; University of Texas Southwestern Medical Center, Dallas, TX
Katherine Holshausen, PhD, McMaster University, Hamilton, Ontario, Canada
Laura Howe-Martin, PhD, ABPP, University of Texas Southwestern Medical Center, Dallas, TX
Mustafa M. Husain, MD, University of Texas Southwestern Medical Center, Dallas, TX; Duke University School of Medicine, Durham, NC
Jutta Joormann, PhD, Yale University, New Haven, CT
Muzaffer Kaser, MD, PhD, University of Cambridge and Cambridgeshire, Cambridge, UK
Sara Kashani, MD, University of Illinois at Chicago, Chicago, IL
Brian Kavanaugh, PsyD, ABPP-CN, E. P. Bradley Hospital/Warren Alpert Medical School, Brown University, Providence, RI
Bonnie Klimes-Dougan, PhD, University of Minnesota, Minneapolis, MN
Tori Knox-Rice, PhD, Colorado Blood Cancer Institute, Presbyterian St. Luke’s Medical Center, Denver, CO
Shellie-Anne Levy, PhD, University of Florida, Gainesville, FL
Sarah H. Lisanby, MD, National Institute of Mental Health, Bethesda, MD; Duke University School of Medicine, Durham, NC
Donel M. Martin, PhD, School of Psychiatry, University of New South Wales, Sydney, Australia
Valeria Martinez-Kaigi, PhD, MS, Hartford Hospital, Hartford, CT; Hartford Healthcare, Westport, CT; Yale School of Medicine, New Haven, CT
Declan M. McLoughlin, PhD, Trinity College Dublin, St Patrick’s University Hospital, Dublin, Ireland
Margaret C. McKinnon, PhD, McMaster University, Hamilton, Ontario, Canada
Heather McNeely, PhD, McMaster University and Clinical Neuropsychology Service, St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada
Melissa Milanovic, PhD, Queen’s University, Kingston, Ontario, Canada
David Mischoulon, MD, Massachusetts General Hospital, and Harvard Medical School, Boston, MA
Adriano Moffa, MPhil, School of Psychiatry, University of New South Wales, Sydney, Australia
Stevan Nikolin, PhD, School of Psychiatry, University of New South Wales, Sydney, Australia
Margaret O’Connor, PhD, Harvard Medical School, Boston, MA
Benjamin D. Pace, MS, University of Iowa Hospitals & Clinics, Iowa City, IA
Aamna Qureshi, MSc, St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, Canada
Joshua Rosenblat, MD, Toronto Western Hospital, and University of Toronto, Toronto, Ontario, Canada
Ashleigh V. Rutherford, MS, MPhil, Yale University, New Haven, CT
Barbara J. Sahakian, PhD, University of Cambridge, Cambridge, UK
Haitham Salem, MD, MSc, PhD, Warren Alpert Medical School, Brown University, Providence, RI
Jerome Sarris, PhD, NICM Health Research Institute, Western Sydney University, Penrith, Australia; Melbourne University, Parkville, Australia
Sudhakar Selvaraj, MBBS, DPhil, MRCPsych, McGovern School of Medicine, University of Texas Health Science Center, Houston, TX
Hunter Small, PhD, University of Texas Southwestern Medical Center, Dallas, TX
Jair C. Soares, MD, PhD, McGovern School of Medicine, University of Texas Health Science Center, Houston, TX
Mariann Suarez, PhD, ABPP, Morsani College of Medicine, University of South Florida Health, Tampa, FL
Michelle Thai, MA, University of Minnesota, Minneapolis, MN
April D. Thames, PhD, University of California, Los Angeles, Los Angeles, CA
Jeena Thomas, MS, National Academies of Sciences, Washington, DC
Tanya Tran, MS, Queen’s University, Kingston, Ontario, Canada
Kayla Tureson, MS, University of Southern California, Los Angeles, CA
Alik S. Widge, MD, University of Minnesota, Minneapolis, MN
Konstantine K. Zakzanis, PhD, CPsych, University of Toronto, Toronto, Ontario, Canada